[Corporate News] Work Conference on Post-Subsidy Support for Capacity Building of R&D Institutions at Key Provincial Enterprises
Release Date:
2021-04-12 15:32
On April 8, the work conference on post‑subsidy support for the capacity building of key enterprise R&D institutions in Jiangsu Province was held in Nanjing. In 2015, 66 Vision Tech Co., Ltd. was included in the third batch of the “Key Enterprise R&D Institutions of Jiangsu Province” list.
The meeting primarily provided an interpretation of the policy on post‑subsidy support for building the capabilities of R&D institutions. At present, the province is home to 999 key enterprise R&D institutions at both the provincial and national levels. In response, the Provincial Enterprise R&D Institution Promotion Association has allocated a special fund of RMB 23.9 million to these 999 institutions, providing financial support for capacity‑building in three key areas: implementing standardized R&D management systems, adopting intellectual property management standards, and conducting training in innovation methodologies. The policy clearly underscores the government’s strong commitment to enhancing corporate R&D capabilities: innovation‑methodology training helps enterprises cultivate innovative talent and highly skilled managers; patent‑driven protection and IP‑standardization systematize intellectual‑property management, guiding companies to carry out related work more effectively and thereby maximizing safeguards against infringement of their core technologies; and the implementation of standardized R&D management systems—introduced in 2015 as a new local standard by the Jiangsu Provincial Bureau of Quality and Technical Supervision—represents both a synthesis and an elevation of these efforts. R&D has long been a top priority for technology‑driven enterprises, and for provincially designated key R&D institutions, rigorous standardization of R&D management is essential to maximize value creation, ensuring that technological innovation serves as the primary engine driving sales growth and output expansion.
At the meeting, several professors also highlighted, from different perspectives, the critical importance of talent, intellectual property, and technological innovation to corporate development. It is precisely for this reason that the provincial department has allocated tens of millions in funding to support enterprises in advancing these three areas. Currently, our company has successfully passed the acceptance review by the provincial expert panel for the intellectual‑property management system standardization and is now preparing to apply for third‑party certification. Meanwhile, guided by relevant policies, the company’s management is beginning to explore the establishment of an R&D management system, which will be integrated into our existing intellectual‑property management framework. These two initiatives are mutually reinforcing and closely interconnected, and we believe they will help elevate our company’s scientific and technological research and development efforts to a new level.
At this conference, numerous companies participated, including several medical device firms from within the province. In the current climate of a sluggish global economy and intensifying domestic market competition, only by steadfastly upholding our commitment to development, prioritizing technological innovation, and investing in talent cultivation can we consolidate our company’s leading position in China’s ophthalmic‑device market and achieve rapid economic growth. We hope that more LULU employees will join this effort and contribute their part to the company’s continued advancement.
Related News
No Clouds in the Fundus, Light in Old Age | National Eye Care Day & Liuliu Vision’s 69th Anniversary
June 6, 2025, marks the 30th National Eye Care Day. According to the “14th Five-Year Plan for National Eye Health,” the leading causes of blindness in China have shifted to conditions such as cataracts and glaucoma.
“Specialized, Refined, Distinctive, and Innovative” enterprises are characterized by specialization, refinement, distinctiveness, and innovation. They focus on niche markets, demonstrate strong innovation capabilities, enjoy high market shares, master critical core technologies, and deliver superior quality and performance, positioning themselves as industry leaders in their respective segments. Since its inception, Liuliu Vision has remained committed to the intelligent manufacturing of ophthalmic medical devices. Drawing on years of industry experience and independent innovation, the company adheres to a development strategy centered on “professionalism, internationalization, cutting-edge technology, high quality, brand building, customer first, and people-oriented principles,” striving to strengthen quality management and enhance product performance. To date, the company operates a provincial-level enterprise technology center and the Jiangsu Provincial Engineering Technology Research Center for Ophthalmic Diagnostic and Therapeutic Devices, and has earned numerous accolades, including being recognized among China’s Top 50 Pharmaceutical Companies and designated as a National High-Tech Enterprise. It has also obtained more than thirty patents across various categories. Being certified this time as a specialized, refined, distinctive, and innovative small and medium-sized enterprise in Jiangsu Province not only underscores Liuliu Vision’s comprehensive strengths—its research capabilities, innovative capacity, and core manufacturing processes—but also provides a powerful impetus for the company’s sustained, healthy growth. Moving forward, Liuliu Vision will continue to attract top-tier technical talent, further elevate its R&D and management standards, ensure technological innovation and cutting-edge advancement, and steadfastly uphold its mission of serving the ophthalmology field with genuine care for eye health.
Our company will be exhibiting at the 22nd Shanghai International Ophthalmology and Optometry Technology & Equipment Exhibition, held from December 9 to 11, 2022, at the Shanghai International Procurement Fair. We warmly welcome both new and longstanding friends to visit!
[Exhibition Notice] 21st China International Eyewear Exhibition
Our company will be exhibiting at the 21st China International Eyewear Exhibition, held in 2022 at the Suzhou International Expo Center. We warmly welcome both new and longstanding friends to visit!
[Exhibition Notice] The 26th National Ophthalmology Conference
Our company will be participating in the 26th National Ophthalmology Conference, to be held from December 14 to 17, 2022, at the China West International Expo City in Chengdu. We warmly welcome both new and longstanding friends to attend!